Inventor

PARENT STEPHAN D

US42 patents

⚠️ This page may combine multiple inventors who share the name “PARENT STEPHAN D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PARENT STEPHAN D

GLOBAL BLOOD THERAPEUTICS INC

Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde

Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde

Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde

Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde

Solid forms of a modulator of hemoglobin

Solid forms of a modulator of hemoglobin

PARENT STEPHAN D

Forms of rifaximin and uses thereof

Forms of rifaximin and uses thereof

Forms of rifaximin and uses thereof

Forms of rifaximin and uses thereof

Form of hexyl-5-aminolevulinate hydrochloride and methods of using the same

TAPPER AMY E

Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents

Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents

Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents

Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents

WALLING JOHN

Forms of CDDO methyl ester

Forms of CDDO methyl ester

Forms of CDDO methyl ester

VITAE PHARMACEUTICALS LLC

Inhibitors of the menin-MLL interaction

Inhibitors of the menin-MLL interaction

Inhibitors of the menin-MLL interaction

WU YIDUO

Forms of rifaximin and uses thereof

Forms of rifaximin and uses thereof

AMGEN INC

Solid state forms

Salt forms and solvates of Mcl-1 antagonists

SUN TONG

Colchicine solid complex; methods of making; and methods of use thereof

Quinine sulfate/bisulfate solid complex; methods of making; and methods of use thereof

IL YANG PHARMACEUTICAL COMPANY LTD

Crystalline forms of solvated ilaprazole

Solid state forms of racemic ilaprazole

BRACKETT JOHN M

Solid state forms of racemic ilaprazole

Solid state forms of racemic ilaprazole

TETRA DISCOVERY PARTNERS INC

Salts and polymorphs of a PDE4 inhibitor

EXELIXIS INC

Crystalline forms and salt forms of a kinase inhibitor

CANNA CHEMISTRIES LLC

Crystalline salts of psilocin

MUTUAL PHARAMACEUTICAL COMPANY INC

Colchicine solid complex; methods of making; and methods of use thereof

CHDI FOUNDATION INC

Solid forms of a kynurenine-3-monooxygenase inhibitor

ONO PHARMACEUTICAL CO

Salt and crystal form of compound having agonistic activity to S1P5 receptor

BHAGWAT SHRIPAD S

Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith

AMBIT BIOSCIENCES CORP

Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith

TELIK INC

Tablet formulation of ezatiostat

VARDA SPACE IND INC

Processes for preparing solid state forms

KALYPSYS INC

Salts of modulators of PPAR and methods of treating metabolic disorders